Vienna, Austria

Annelies Klima


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Annelies Klima: Pioneering Innovations in HIV Vaccine Development

Introduction

Annelies Klima, an innovative inventor based in Vienna, Austria, has made significant contributions to the field of immunology, particularly in the development of vaccines. With two patents to her name, her work focuses on creating effective solutions for the prevention and treatment of HIV infections, showcasing her dedication to addressing global health challenges.

Latest Patents

Klima's most recent patents revolve around HIV vaccines. These patents disclose antibodies that can be utilized for the manufacture of vaccines aimed at active and/or passive immunization of individuals in need. The inventions provide human monoclonal antibodies that are functionally equivalent to those produced by various cell lines deposited at the European Collection of Animal Cell Cultures (ECACC) at the PHLS in Porton Down, Salisbury, UK. Additionally, the patents include hybridoma and CHO cell lines that produce these antibodies. They also detail mixtures of antibodies for the detection, prevention, and treatment of HIV-1 infections, both in vitro and in vivo, underscoring the potential impact of her work on public health.

Career Highlights

Throughout her career, Annelies Klima has been associated with notable companies in the field of scientific research. She has worked with Polynum Scientific Immunbiologische Forschung GmbH and Polymun Scientific Immunbiologische Forschung GmbH. Her research and contributions have positioned her as a prominent figure in immunobiological research, particularly concerning HIV.

Collaborations

Klima’s collaborative efforts with esteemed colleagues such as Hermann W. Katinger and Andrea Buchacher have been instrumental in advancing her research. These collaborations have not only enhanced her work but have also fostered a community of dedication toward combatting viral infections through innovative vaccine solutions.

Conclusion

Annelies Klima’s innovations in the field of HIV vaccine research demonstrate her commitment to scientific advancement and public health. With a focus on developing effective antibodies and vaccines, she is poised to make lasting contributions to the fight against HIV, marking her as a key inventor in the realm of immunobiological research. Her achievements highlight the importance of continued innovation and collaboration in addressing ongoing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…